Category: Modafinil

NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Posted on | Posted on John Murphy | Leave a Comment on NIH to open long COVID clinical trials to study sleep disturbances, exercise intolerance, and post exertional malaise

Part of the NIH RECOVER Initiative, trials will test four treatments. The National Institutes of Health (NIH) will launch clinical trials to investigate potential treatments for long-term symptoms after COVID-19 infection, including sleep disturbances, exercise intolerance and the worsening of symptoms following physical or mental exertion known as post-exertional malaise (PEM). The mid-stage trials, part […]

Narcolepsy following COVID‐19: A case report and review of potential mechanisms

Posted on | Posted on John Murphy | Leave a Comment on Narcolepsy following COVID‐19: A case report and review of potential mechanisms

Yazdani Roya, 1 Barzkar Farzaneh, 2 Almasi‐Dooghaee Mostafa, 1 Shojaie Mahsa, 1 and Zamani Babak 1 Clin Case Rep. 2023 Jun; 11(6): e7370. Published online 2023 May 25.https://doi.org/10.1002/ccr3.7370, PMCID: PMC10213711, PMID: 37251741 Abstract Key Clinical Message The immune activation in COVID‐19 may trigger narcolepsy in vulnerable patients. We suggest clinicians carefully evaluate patients with post‐COVID fatigue and hypersomnia for primary sleep disorders, specifically narcolepsy. Abstract The patient […]

Narcolepsy following COVID‐19: A case report and review of potential mechanisms

Posted on | Posted on John Murphy | Leave a Comment on Narcolepsy following COVID‐19: A case report and review of potential mechanisms

Yazdani Roya, 1 Barzkar Farzaneh, 2 Almasi‐Dooghaee Mostafa, 1 Shojaie Mahsa, 1 and Zamani Babak 1 Clin Case Rep. 2023 Jun; 11(6): e7370. Published online 2023 May 25. doi: 10.1002/ccr3.7370 PMCID: PMC10213711, PMID: 37251741 Key Clinical Message The immune activation in COVID‐19 may trigger narcolepsy in vulnerable patients. We suggest clinicians carefully evaluate patients with post‐COVID fatigue and hypersomnia for primary sleep disorders, specifically narcolepsy. Abstract The patient is a […]